Unlike us, the company is not overly concerned about the share market and just plodding along fulfilling regulatory requirements and negotiating business contracts on their strategic aim of developing commercial pathways. If they courted the share market a little better we'd probably be a bit higher, but ultimately I'd rather them concentrate on trials, approvals and partnerships.
FDA significance, page-431
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.5¢ |
Change
-0.020(2.92%) |
Mkt cap ! $159.0M | |||
| Open | High | Low | Value | Volume |
| 67.0¢ | 67.0¢ | 65.0¢ | $245.7K | 371.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15000 | 65.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.5¢ | 12621 | 2 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |